Yuyu Pharma, Inc.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 000227.KS | 000100.KS | 033270.KS | 600351.SS | 600521.SS | 600812.SS | |
|---|---|---|---|---|---|---|
| Market cap | — | 6.33T | 270.11B | 4.75B | 25.05B | 8.39B |
| P/E (TTM) | — | — | — | 14.9 | 39.8 | 69.9 |
| Forward P/E | — | — | — | — | 50.7 | — |
| Price/book | — | — | — | 1.7 | 2.6 | 1.5 |
| Dividend yield | 1.65% | 0.71% | 3.55% | 8.31% | 0.62% | 0.71% |
| 1-year change | −26.76% | −26.38% | −8.56% | −1.78% | −12.76% | −19.08% |
| Today | −1.85% | +0.83% | −0.99% | +3.63% | +3.72% | −0.61% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 000227.KS news ›Yuyu Pharma Develops Capsule Technology Combining Different Dosage Forms
Tablets, Soft Capsules and Pellets Combined in a Single Hard Capsule Independent Design for Each Ingredient Controls Release Rates, Widening Use in Combination Drug Development Yuyu Pharma said on the 19th that it has developed YUNICAP, a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
en.sedaily.com2
-
koreabiomed.com1
-
manilatimes.net1
-
prnewswire.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.